The evolution of transdermal therapy for overactive bladder

Current Urology Reports

Volumn 10, Issue 5, 2009, Pages 338-341

  Sand, Peter K ^a  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; DRUG METABOLITE; N DESETHYLOXYBUTYNIN; OXYBUTYNIN; PLACEBO; UNCLASSIFIED DRUG;

CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRY EYE; HUMAN; INTESTINE; LIVER; OVERACTIVE BLADDER; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN MANIFESTATION; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ADMINISTRATION, CUTANEOUS; GELS; HUMANS; MANDELIC ACIDS; MUSCARINIC ANTAGONISTS; URINARY BLADDER, OVERACTIVE;

EID: 69249192979     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-009-0053-4     Document Type: Review

References (17)

1. C.B. Brendler L.C. Radebaugh J.L. Mohler 1989 Topical oxybutynin chloride for relaxation of dysfunctional bladders J Urol 141 1350 1352
2. C.A. Massad B.A. Kogan F.E. Trigo-Rocha 1992 The pharmacokinetics of intravesical and oral oxybutynin chloride J Urol 148 595 597
3. R.A. Appell M.B. Chancellor R.H. Zobrist, et al. 2003 Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects Mayo Clin Proc 78 696 702
4. H.A. Winkler P.K. Sand 1998 Treatment of detrusor instability with oxybutynin rectal suppositories Int Urogynecol J Pelvic Floor Dysfunct 9 100 102
5. G. Sathyan M.B. Chancellor S.K. Gupta 2001 Effect of OROS controlled-release delivery on the pharmacokinetics and pharmacodynamics of oxybutynin chloride Br J Clin Pharmacol 52 409 417
6. D.M. Gleason J. Susset C. White, et al. 1999 Evaluation of a new once-daily formulation of oxybutynin for treatment of urinary urge incontinence Urology 54 420 423
7. R.R. Dmochowski G.W. Davila N.R. Zinner, et al. 2002 Efficacy and safety of transdermal oxybutynin in patients with urge and mixed urinary incontinence J Urol 168 580 586
8. G.W. Davila C.A. Daugherty S.W. Sanders the Transdermal Oxybutynin Study Group 2001 A short-term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence J Urol 166 140 145
9. R.R. Dmochowski V. Nitti D. Staskin, et al. 2005 Transdermal oxybutynin in the treatment of adults with overactive bladder: combined results of two randomized clinical trials World J Urol 23 263 271
10. P. Sand N. Zinner D. Newman, et al. 2007 Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community-based, randomized study BJU Int 99 836 844
11. P.K. Sand R.P. Goldberg R.R. Dmochowski, et al. 2006 The impact of the overactive bladder syndrome on sexual function: a preliminary report from the multicenter assessment of transdermal therapy in overactive bladder with oxybutynin trial Am J Obstet Gynecol 195 1730 1735
12. L.T. Pizzi A. Talati E. Gemmen, et al. 2009 Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study Pharmacoeconomics 27 329 339
13. Caramelli KE, Staskin DR, Volinn W: Steady-state pharmacokinetics of an investigational oxybutynin topical gel in comparison with oxybutynin transdermal system [abstract 1508]. Poster presented at the Annual Meeting of the American Urological Association. Orlando, FL; May 17-22, 2008.
14. D.R. Staskin R.R. Dmochowski P.K. Sand, et al. 2009 Efficacy and safety of oxybutynin chloride topical gel for treatment of adults with overactive bladder: a randomized, double-blind, placebo-controlled, multicenter study J Urol 181 1764 1772
15. R.R. Dmochowski P.K. Sand N.R. Zinner, et al. 2003 Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence Urology 62 237 242
16. Caramelli KE, Stanworth S, Volinn W, Hoel G: Pharmacokinetics of oxybutynin topical gel: effects of showering, sunscreen application, and person-to-person transference. Poster presented at the Annual Meeting of the American College of Clinical Pharmacy. Louisville, KY; October 19-22, 2008.
17. Caramelli KE, Thomas H, Stanworth S, Hoel G: Steadystate bioavailability of oxybutynin topical gel at 3 different application sites. Poster presented at the Annual Meeting of the American Society of Consultant Pharmacists. New Orleans, LA; November 19-22, 2008.